Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
Q1 2026 earnings • released • EPS beat +10 388,80% • Revenue beat +0,22%
See results
GSK:NYSE
GSK plc
51,61 USD
-1,34%
(-0,70) 1D
51,60 USD
-0,02% (-0,010)
After hours
Closed: 1-май, 16:00:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GSK...
Open
51,80 USD
High
52,23 USD
Low
51,52 USD
Mkt. cap
103,94 млд
Volume
3,94 млн
Dividend
3,44%
Quarterly dividend
0,44 USD
Ex dividend date
2026-ж., 14-май
P/E ratio
13,32
52-wk high
61,70 USD
52-wk low
35,45 USD
EPS
3,87 USD
Beta
0,37
Shares outstanding
2,03 млд
No. of employees
67 миң
News stories
From sources across the web
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England. GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK. The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About GSK plc
CEOEmma Walmsley | Emma Walmsley
Employees66,8 миң
Founded2000-ж., 27-дек.
Headquarters-
SectorPharmaceutical industry
Websitegsk.com
Last report
2026-ж., 29-апр.
Fiscal Period
Q1 2026
Normalized EPS / Estimate
46,50/ (0,44 est.)GBP
+10 388,80%beat
Revenue / Estimate
7,63 млд/ (7,61 млд est.)GBP
+0,22%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
7,99 млд
8,55 млд
8,62 млд
7,63 млд
Cost of goods sold
2,16 млд
2,24 млд
2,62 млд
-
Cost of revenue
2,16 млд
2,24 млд
2,62 млд
-
Research and development expenses
1,54 млд
1,58 млд
2,14 млд
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,13 млд
2,16 млд
2,67 млд
-
Operating expense
3,43 млд
3,23 млд
4,37 млд
-
Total operating expenses
5,59 млд
5,46 млд
6,99 млд
-
Operating income
2,39 млд
3,08 млд
1,63 млд
-
Other non operating income
-
-
-21,00 млн
-
EBT including unusual items
1,89 млд
2,46 млд
950,00 млн
-
EBT excluding unusual items
2,26 млд
2,94 млд
1,48 млд
-
Income tax expense
241,00 млн
312,00 млн
223,00 млн
-
Effective tax rate
12,77%
12,70%
23,47%
-
Other operating expenses
-246,00 млн
-511,00 млн
-434,00 млн
-
Net income
1,44 млд
2,01 млд
636,00 млн
-
Net profit margin
18,07%
23,55%
7,38%
-
Earnings per share
0,46
0,55
-
-
Interest and investment income
50,00 млн
26,00 млн
17,00 млн
-
Interest expense
-184,00 млн
-167,00 млн
-145,00 млн
-
Net interest expenses
-134,00 млн
-141,00 млн
-128,00 млн
-
Depreciation and amortization charges
-
-
-
-
EBITDA
3,55 млд
3,82 млд
2,69 млд
-
Gain or loss from assets sale
-
-
-40,00 млн
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer